Medicare Enrolled

Dr. Harresh Dulamal, M.D.

Family Medicine · Savannah, GA
Low-engagement
9 CHATHAM CTR S, Savannah, GA 31405
9125277211
In practice since 2005 (20 years)
NPI: 1699773457 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dulamal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dulamal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dulamal

Dr. Harresh Dulamal is a family medicine specialist in Savannah, GA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Dulamal received a total of $4,394 from 41 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dulamal is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $4,394 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$4,394
Total received (2018-2023)
Avg $732/year across 6 years
Top 16% in GA for family medicine
41
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,394 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$22
2022
$774
2021
$977
2020
$609
2019
$905
2018
$1,107

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$775
AstraZeneca Pharmaceuticals LP
$703
PFIZER INC.
$457
Amgen Inc.
$323
Boehringer Ingelheim Pharmaceuticals, Inc.
$272
Astellas Pharma US Inc
$221
Amarin Pharma Inc.
$219
Lilly USA, LLC
$176
SANOFI-AVENTIS U.S. LLC
$145
Kowa Pharmaceuticals America, Inc.
$138
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$81
Sunovion Pharmaceuticals Inc.
$81
Novartis Pharmaceuticals Corporation
$75
AbbVie Inc.
$67
Merck Sharp & Dohme Corporation
$62
Biohaven Pharmaceutical Holding Company Ltd.
$57
Boston Scientific Corporation
$55
Esperion Therapeutics, Inc.
$53
Genentech USA, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$41
Shire North American Group Inc
$30
GlaxoSmithKline, LLC.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
Hologic, LLC
$19
IDORSIA PHARMACEUTICALS US INC
$19
Pfizer Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
AbbVie, Inc.
$17
ABBVIE INC.
$16
LIFESCAN, INC.
$16
Janssen Pharmaceuticals, Inc
$15
Arbor Pharmaceuticals, Inc.
$14
Shield Therapeutics Inc
$14
Eisai Inc.
$14
SANOFI PASTEUR INC.
$14
Horizon Therapeutics plc
$14
Hikma Pharmaceuticals USA
$13
Paratek Pharmaceuticals, Inc.
$13
IBSA Pharma Inc.
$12
Aytu Bioscience, Inc
$12
Endo Pharmaceuticals Inc.
$12
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · AJOVY · APTIMA · APTIOM · Aimovig · AirDuo Digihaler · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · Dayvigo · ELIQUIS · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · GENERAL PAIN MANAGEMENT · General - Pain Management · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LYRICA · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Mitigare · NASCOBAL · NEXLETOL · NURTEC ODT · NUZYRA · Natesto · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · Saxenda · Synthroid · TOUJEO · TOVIAZ · TRINTELLIX · TRULICITY · Tirosint · Tresiba · UBRELVY · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Savannah?
Compare family medicine physicians in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
146
Per 100K population
49.0
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dulamal is a family medicine specialist, with low-engagement industry engagement in the top 16% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Dulamal receive payments from pharmaceutical companies?
Yes. Dr. Dulamal received a total of $4,394 from 41 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Dulamal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →